Chandan Saurabh, Khan Shahab R, Mohan Babu P, Shah Aun R, Bilal Mohammad, Ramai Daryl, Bhogal Neil, Dhindsa Banreet, Kassab Lena L, Singh Shailendra, Ponnada Suresh, Nguyen Andrew K, McDonough Stephanie, Adler Douglas G
Division of Gastroenterology, CHI Creighton University Medical Center, Omaha, Nebraska, United States.
Section of Gastroenterology, Rush University Medical Center, Chicago, Illinois, USA.
Endosc Int Open. 2021 Mar;9(3):E496-E504. doi: 10.1055/a-1341-0788. Epub 2021 Feb 22.
Endoscopic and surgical techniques have been utilized for palliation of gastric outlet obstruction (GOO). Enteral stenting (ES) is an established technique with high clinical success and low morbidity rate. Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) is a novel approach that aims to provide sustained palliation of GOO. We conducted a comprehensive review and meta-analysis to evaluate the effectiveness in terms of clinical and technical success, as well as the safety profile of EUS-GE and ES. We searched multiple databases from inception through July 2020 to identify studies that reported on safety and effectiveness of EUS-GE in comparison to ES. Pooled rates of technical success, clinical success, and adverse events (AEs) were calculated. Study heterogeneity was assessed using I % and 95 % confidence interval. Five studies including 659 patients were included in our final analysis. Pooled rate of technical and clinical success for EUS-GE was 95.2 % (CI 87.2-.98.3, I = 42) and 93.3 % (CI 84.4-97.3, I = 59) while for ES it was 96.9 % (CI 90.9-99, I = 64) and 85.6 % (CI 73-92.9, I = 85), respectively. Pooled rate of re-intervention was significantly lower with EUS-GE i. e. 4 % (CI 1.8-8.7, I = 35) compared to ES, where it was 23.6 % (CI 17.5-31, I = 35), p = 0.001 Pooled rates of overall and major AEs were comparable between the two techniques. EUS-GE is comparable in terms of technical and clinical effectiveness and has a similar safety profile when compared to ES for palliation of GOO.
内镜和手术技术已被用于缓解胃出口梗阻(GOO)。肠内支架置入术(ES)是一种成熟的技术,临床成功率高且发病率低。内镜超声引导下胃肠造口术(EUS-GE)是一种旨在为GOO提供持续缓解的新方法。我们进行了一项全面的综述和荟萃分析,以评估EUS-GE和ES在临床和技术成功率方面的有效性以及安全性。我们检索了从开始到2020年7月的多个数据库,以确定报告EUS-GE与ES相比安全性和有效性的研究。计算技术成功率、临床成功率和不良事件(AE)的合并率。使用I²%和95%置信区间评估研究异质性。我们的最终分析纳入了五项研究,共659例患者。EUS-GE的技术和临床成功率合并率分别为95.2%(CI 87.2-.98.3,I²=42)和93.3%(CI 84.4-97.3,I²=59),而ES的分别为96.9%(CI 90.9-99,I²=64)和85.6%(CI 73-92.9,I²=85)。与ES相比,EUS-GE的再次干预合并率显著更低,即4%(CI 1.8-8.7,I²=35),而ES为23.6%(CI 17.5-31,I²=35),p=0.001。两种技术的总体和主要AE合并率相当。对于缓解GOO,EUS-GE在技术和临床有效性方面相当,与ES相比具有相似的安全性。